About Shanghai Pharmaceuticals Holding
Shanghai Pharmaceuticals Holding is a company based in Shanghai (China) founded in 1994.. Shanghai Pharmaceuticals Holding has raised $159.89 million across 1 funding round from investors including New Alliance Capital. The company has 49,400 employees as of December 31, 2024. Shanghai Pharmaceuticals Holding has completed 2 acquisitions, including RIEMSER Pharma and Vitaco.
- Headquarter Shanghai, China
- Employees 49400 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Shanghai Pharmaceuticals Holding Co. Ltd. Class A
-
Annual Revenue
$37.6 B (USD)5.75as on Dec 31, 2024
-
Net Profit
$623.34 M (USD)20.82as on Dec 31, 2024
-
EBITDA
$1.55 B (USD)7.12as on Dec 31, 2024
-
Total Equity Funding
$159.89 M (USD)
in 1 rounds
-
Latest Funding Round
$159.89 M (USD), Series B
Feb 18, 2021
- Investors
-
Employee Count
49400
as on Dec 31, 2024
-
Investments & Acquisitions
RIEMSER Pharma
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Shanghai Pharmaceuticals Holding
Shanghai Pharmaceuticals Holding is a publicly listed company on the SSE with ticker symbol 601607 in China, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Funding Insights of Shanghai Pharmaceuticals Holding
Shanghai Pharmaceuticals Holding has successfully raised a total of $159.89M through 1 strategic funding round. The most recent funding activity was a Series B round of $159.89 million completed in February 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series B — $159.9M
-
First Round
First Round
(18 Feb 2021)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2021 | Amount | Series B - Shanghai Pharmaceuticals Holding | Valuation | New Alliance Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Shanghai Pharmaceuticals Holding
Shanghai Pharmaceuticals Holding has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include New Alliance Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
PE firm invests in China
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Shanghai Pharmaceuticals Holding
Shanghai Pharmaceuticals Holding has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include RIEMSER Pharma and Vitaco. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Health foods, sports nutrition, and supplements are manufactured.
|
2007 | ||||
|
Contract development and manufacturing services for pharmaceutical APIs are provided.
|
2000 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Shanghai Pharmaceuticals Holding
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Shanghai Pharmaceuticals Holding Comparisons
Competitors of Shanghai Pharmaceuticals Holding
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Shanghai Pharmaceuticals Holding
Frequently Asked Questions about Shanghai Pharmaceuticals Holding
When was Shanghai Pharmaceuticals Holding founded?
Shanghai Pharmaceuticals Holding was founded in 1994 and raised its 1st funding round 27 years after it was founded.
Where is Shanghai Pharmaceuticals Holding located?
Shanghai Pharmaceuticals Holding is headquartered in Shanghai, China.
Who is the current CEO of Shanghai Pharmaceuticals Holding?
Man Cho is the current CEO of Shanghai Pharmaceuticals Holding.
Is Shanghai Pharmaceuticals Holding a funded company?
Shanghai Pharmaceuticals Holding is a funded company, having raised a total of $159.89M across 1 funding round to date. The company's 1st funding round was a Series B of $159.89M, raised on Feb 18, 2021.
How many employees does Shanghai Pharmaceuticals Holding have?
As of Dec 31, 2024, the latest employee count at Shanghai Pharmaceuticals Holding is 49,400.
What is the annual revenue of Shanghai Pharmaceuticals Holding?
Annual revenue of Shanghai Pharmaceuticals Holding is $37.6B as on Dec 31, 2024.
What does Shanghai Pharmaceuticals Holding do?
Shanghai Pharmaceuticals Group is the only integrated pharmaceutical company in the PRC that has leading positions in both pharmaceutical product and distribution markets. It was Chinassecond-largest pharmaceutical distributor and third-largest pharmaceutical producer. The Group adopts an integrated vertical business model and provides solutions in pharmaceutical manufacturing, distribution, logistics storage and retail. The Group currently offers more than 400 pharmaceutical products as well as pharmaceutical distribution and supply chain solutions to more than 7,600 hospitals and medical institutions in China. The Group also operates approximately 1,700 self-operated and franchise stores nationwide. In 2022, the company recorded annual revenues of 35.1B and a net profit of 0.87B.
Is Shanghai Pharmaceuticals Holding publicly traded?
Yes, Shanghai Pharmaceuticals Holding is publicly traded on SSE under the ticker symbol 601607.
How many acquisitions has Shanghai Pharmaceuticals Holding made?
Shanghai Pharmaceuticals Holding has made 2 acquisitions, including RIEMSER Pharma, and Vitaco.
Who are Shanghai Pharmaceuticals Holding's investors?
Shanghai Pharmaceuticals Holding has 1 investor. Key investors include New Alliance Capital.
What is Shanghai Pharmaceuticals Holding's ticker symbol?
The ticker symbol of Shanghai Pharmaceuticals Holding is 601607 on SSE.